Correlation Between Novartis and Omeros
Can any of the company-specific risk be diversified away by investing in both Novartis and Omeros at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Omeros into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG ADR and Omeros, you can compare the effects of market volatilities on Novartis and Omeros and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Omeros. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Omeros.
Diversification Opportunities for Novartis and Omeros
Excellent diversification
The 3 months correlation between Novartis and Omeros is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG ADR and Omeros in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Omeros and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG ADR are associated (or correlated) with Omeros. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Omeros has no effect on the direction of Novartis i.e., Novartis and Omeros go up and down completely randomly.
Pair Corralation between Novartis and Omeros
Considering the 90-day investment horizon Novartis AG ADR is expected to generate 0.26 times more return on investment than Omeros. However, Novartis AG ADR is 3.9 times less risky than Omeros. It trades about 0.29 of its potential returns per unit of risk. Omeros is currently generating about -0.1 per unit of risk. If you would invest 9,714 in Novartis AG ADR on November 3, 2024 and sell it today you would earn a total of 758.00 from holding Novartis AG ADR or generate 7.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Novartis AG ADR vs. Omeros
Performance |
| Timeline |
| Novartis AG ADR |
| Omeros |
Novartis and Omeros Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novartis and Omeros
The main advantage of trading using opposite Novartis and Omeros positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Omeros can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omeros will offset losses from the drop in Omeros' long position.| Novartis vs. AstraZeneca PLC ADR | Novartis vs. GlaxoSmithKline PLC ADR | Novartis vs. Roche Holding Ltd | Novartis vs. Bristol Myers Squibb |
| Omeros vs. Crinetics Pharmaceuticals | Omeros vs. Enanta Pharmaceuticals | Omeros vs. Amicus Therapeutics | Omeros vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |